- Home
- SXTP vs ATNF Comparison
SXTP vs ATNF Comparison
Compare SXTP & ATNF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SXTP
- ATNF
- Stock Information
- Founded
- SXTP 2010
- ATNF 2016
- Country
- SXTP United States
- ATNF United States
- Employees
- SXTP N/A
- ATNF N/A
- Industry
- SXTP Biotechnology: Pharmaceutical Preparations
- ATNF Biotechnology: Pharmaceutical Preparations
- Sector
- SXTP Health Care
- ATNF Health Care
- Exchange
- SXTP Nasdaq
- ATNF Nasdaq
- Market Cap
- SXTP 4.3M
- ATNF 3.8M
- IPO Year
- SXTP 2023
- ATNF N/A
- Fundamental
- Price
- SXTP $2.32
- ATNF $0.83
- Analyst Decision
- SXTP Buy
- ATNF
- Analyst Count
- SXTP 2
- ATNF 0
- Target Price
- SXTP $7.00
- ATNF N/A
- AVG Volume (30 Days)
- SXTP 324.9K
- ATNF 35.4K
- Earning Date
- SXTP 08-13-2025
- ATNF 08-11-2025
- Dividend Yield
- SXTP N/A
- ATNF N/A
- EPS Growth
- SXTP N/A
- ATNF N/A
- EPS
- SXTP N/A
- ATNF N/A
- Revenue
- SXTP $802,323.00
- ATNF N/A
- Revenue This Year
- SXTP $95.50
- ATNF N/A
- Revenue Next Year
- SXTP $80.78
- ATNF N/A
- P/E Ratio
- SXTP N/A
- ATNF N/A
- Revenue Growth
- SXTP 118.37
- ATNF N/A
- 52 Week Low
- SXTP $1.41
- ATNF $0.66
- 52 Week High
- SXTP $35.99
- ATNF $17.75
- Technical
- Relative Strength Index (RSI)
- SXTP 50.64
- ATNF 35.60
- Support Level
- SXTP $1.91
- ATNF $0.95
- Resistance Level
- SXTP $2.55
- ATNF $1.04
- Average True Range (ATR)
- SXTP 0.24
- ATNF 0.08
- MACD
- SXTP -0.00
- ATNF -0.01
- Stochastic Oscillator
- SXTP 46.09
- ATNF 17.41
About SXTP 60 Degrees Pharmaceuticals Inc.
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.
About ATNF 180 Life Sciences Corp.
180 Life Sciences Corp was formed as a clinical-stage biotechnology company, focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation, and fibrosis by employing research, and, where appropriate, combination therapy. In addition, it has acquired certain source code and intellectual property relating to the back-end technology platform to operate an online blockchain casino, and moving forward, it plans to focus the majority of its operations on the creation of the online blockchain casino, while looking to monetize certain prior development-stage therapeutic product candidates for unmet medical needs. It has one reportable operating segment, iGaming.